Vendor source

Reviewed 11 May 2026

Completeness Strong (72%)

CINA-LVO

Avicenna.AI

The CINA-LVO solution is designed to automatically detect and prioritize acute large vessel occlusions on CTA.

Supported by 4 papers

Key Features

  • Large vessel occlusion detection
  • Notification

General Information

Product name

CINA-LVO

Modality

CT

Main task

Not specified

Subspeciality

Neuro

Disease targeted

Stroke

Regulatory Information

CE Certification

Pathway:

MDR

Class:

Class IIb

Verified by Health AI Register

FDA Certification

Pathway:

510(k) cleared

Class:

Class II

Verified by Health AI Register

Other certifications

Not specified

Technical Specifications

Patient population age

Not specified

Input

Brain CTA

Input format

DICOM

Output

bounding box, worklist order, notification

Output format

DICOM SC, GSPS

Integration

Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform

Deployment

Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)

Trigger for analysis

Automatically, right after the image acquisition

Processing time

10 - 60 seconds

Population

Suspicion of stroke

Market Presence

On market since

02-2020

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Subscription

Based on

Number of analyses, Number of installations

Source: Vendor | First published: Jul 9, 2024 | Last updated: May 11, 2026

CINA-LVO - Avicenna.AI